Visceral Leishmaniasis Revealing Undiagnosed Inborn Errors of Immunity.
Journal
Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
08
2023
accepted:
26
10
2023
medline:
27
11
2023
pubmed:
17
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
Visceral Leishmaniasis (VL) is a potentially fatal disease and may be associated with primary or acquired immunodeficiencies. There are few reports, in the literature, of inborn errors of immunity. Here, we report two cases of VL as a marker of inborn errors of immunity, namely, GATA2 and RAB27A deficiency. Our data suggest that VL patients should be screened for primary immunodeficiency, particularly in cases of VL relapse.
Identifiants
pubmed: 37970879
pii: S0037-86822023000100710
doi: 10.1590/0037-8682-0322-2023
pmc: PMC10637728
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e03222023Références
Future Microbiol. 2014;9(7):901-15
pubmed: 25156379
Pediatr Blood Cancer. 2017 Jun;64(6):
pubmed: 27873456
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S11
pubmed: 22165913
J Clin Immunol. 2016 May;36(4):363-5
pubmed: 26984850
Br J Haematol. 2015 Apr;169(2):173-87
pubmed: 25707267
Med J Malaysia. 2014 Aug;69(4):193-4
pubmed: 25500851
Dermatol Online J. 2007 May 01;13(2):17
pubmed: 17498436
Clin Microbiol Infect. 2014 Apr;20(4):286-99
pubmed: 24450618
Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):104-9
pubmed: 25397911
Pediatr Allergy Immunol. 2022 Jan;33(1):e13653
pubmed: 34407251
J Chemother. 2017 Oct;29(5):261-266
pubmed: 28490252
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638